Geistlich biomaterials

Dental treatments are a matter of trust: our experience and expertise is something you can rely on.

Biomaterials from Geistlich Pharma AG are the most frequently used materials in regenerative dentistry throughout the world.1-7 Over 15 million patients worldwide have been treated with them.8

  • Geistlich products are high quality Swiss biomaterials.
  • They were evaluated in more than 1,400 scientific publications from countries all over the world.
  • Meticulous selection of raw materials, together with a strictly controlled manufacturing process, allows Geistlich biomaterials to conform to high safety requirements and ensures high tolerability.
  • These are medical devices in conformance with the applicate market requirements for safety and performance as confirmed by international and national regulatory bodies.

 

The information in this website is solely provided for information purposes. Such information is not meant to be a substitute for advice provided by a dentist.

 

References:

  1. Europe market report suite for dental bone graft substitutes and other biomaterials, iDATA_EUDBGS19_MS, Published in July 2019 by iData Research Inc., 2019
  2. China market report suite for dental bone graft substitutes and other biomaterials, iDATA_CHDBGS18_MS, Published in November 2018 by iData Research Inc., 2018
  3. Australia market report suite for dental bone graft substitutes and other biomaterials, iDATA_AUDBGS18_MS, Published in November 2018 by iData Research Inc., 2018
  4. India market report suite for dental bone graft substitutes and other biomaterials, iDATA_INDBGS18_MS, Published in November 2018 by iData Research Inc., 2018
  5. South Korea market report suite for dental bone graft substitutes and other biomaterials, iDATA_SKDBGS18_MS, Published in November 2018 by iData Research Inc., 2018
  6. Japan market report suite for dental bone graft substitutes and other biomaterials, iDATA_JPDBGS18_MS, Published in November 2018 by iData Research Inc., 2018
  7. US market report suite for dental bone graft substitutes and other biomaterials, iDATA_USDBGS19_MS, Published in January 2019 by iData Research Inc., 2019
  8. Numbers on Geistlich product use: data on file, Geistlich Pharma AG

 

Verena Vermeulen
Senior Scientific Communication Manager